Published in Carcinogenesis on May 01, 1990
Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A (1993) 13.27
The causes and prevention of cancer. Proc Natl Acad Sci U S A (1995) 3.71
Chemical carcinogenesis: too many rodent carcinogens. Proc Natl Acad Sci U S A (1990) 2.60
Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ Health Perspect (1993) 0.99
Compensatory regeneration, mitogen-induced liver growth, and multistage chemical carcinogenesis. Environ Health Perspect (1993) 0.87
Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect (1993) 0.87
Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am J Pathol (1996) 0.79
Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment. Environ Health Perspect (1993) 0.77
Peripheral blood signatures of lead exposure. PLoS One (2011) 0.75
The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev Cell (2001) 2.89
Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol (1998) 2.62
Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest (2003) 1.60
Acute methylprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans. Eur J Clin Invest (1999) 1.47
Diminished response to cytotoxic therapy in G-6-PD deficiency. Lancet (1980) 1.39
Neural correlates of cognitive control of reaching movements in the dorsal premotor cortex of rhesus monkeys. J Neurophysiol (2011) 1.29
Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J Hepatol (1999) 1.28
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Hepatic cholesterol in lead nitrate induced liver hyperplasia. Chem Biol Interact (1984) 1.26
Association between v-Src and protein kinase C delta in v-Src-transformed fibroblasts. J Biol Chem (1997) 1.22
Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer (1994) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Massive liver replacement by transplanted hepatocytes in the absence of exogenous growth stimuli in rats treated with retrorsine. Am J Pathol (2001) 1.17
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression. Oncogene (2012) 1.11
A growth-constrained environment drives tumor progression invivo. Proc Natl Acad Sci U S A (2001) 1.11
Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest (1985) 1.09
Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells. A sequential study. Am J Pathol (1984) 1.09
Induction of two different modes of cell death, apoptosis and necrosis, in rat liver after a single dose of thioacetamide. Am J Pathol (1991) 1.09
Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia. Br J Haematol (1997) 1.08
Increased ROS generation and p53 activation in alpha-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis (2007) 1.08
Choline-deficiency fatty liver: impaired release of hepatic triglycerides. J Lipid Res (1968) 1.08
Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br J Cancer (1992) 1.06
In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene (1998) 1.02
Cyclin D1 is an early target in hepatocyte proliferation induced by thyroid hormone (T3). FASEB J (2001) 1.00
Cell deletion by apoptosis during regression of renal hyperplasia. Am J Pathol (1989) 0.98
Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis (1995) 0.97
Hepatic glucose-6-phosphate dehydrogenase, cholesterogenesis, and serum lipoproteins in liver regeneration after partial hepatectomy. Exp Mol Pathol (1986) 0.97
Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res (1987) 0.96
Plasma polychlorobiphenyl and organochlorine pesticide level and risk of major lymphoma subtypes. Occup Environ Med (2007) 0.96
Increased expression of c-fos, c-jun and LRF-1 is not required for in vivo priming of hepatocytes by the mitogen TCPOBOP. Oncogene (1997) 0.95
An electron microscopic study of apoptosis induced by cycloheximide in rat liver. Liver (1994) 0.93
Differences in the steady-state levels of c-fos, c-jun and c-myc messenger RNA during mitogen-induced liver growth and compensatory regeneration. Hepatology (1993) 0.91
Surface markers on lymphocytes from human cerebrospinal fluid. Identification by monoclonal antibodies. J Neuroimmunol (1983) 0.90
Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol (1991) 0.90
Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration. Cell Prolif (2008) 0.89
Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol (1983) 0.89
Sexually differentiated response to choline in choline deficiency and ethionine intoxication. Int J Exp Pathol (1995) 0.88
Effects of cell proliferation and cell death (apoptosis and necrosis) on the early stages of rat hepatocarcinogenesis. Carcinogenesis (1996) 0.88
Liver hyperplasia is not necessarily associated with increased expression of c-fos and c-myc mRNA. Carcinogenesis (1990) 0.87
Mitogenesis by ligands of nuclear receptors: an attractive model for the study of the molecular mechanisms implicated in liver growth. Cell Death Differ (2003) 0.87
Variations of serum lipoproteins during cell proliferation induced by lead nitrate. Exp Mol Pathol (1989) 0.87
Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem J (1997) 0.86
Expression of MHC class I and class II antigens in pancreatic adenocarcinomas. Tissue Antigens (1996) 0.86
Serum lipoprotein pattern as modified in G6PD-deficient children during haemolytic anaemia induced by fava bean ingestion. Int J Exp Pathol (1992) 0.86
Choline enhances acetylaminofluorene promotion of liver carcinogenesis in female but not in male rats. Carcinogenesis (1992) 0.86
Acinar cell carcinoma of rat pancreas: regulation of cholesterol esterification. Br J Cancer (1986) 0.86
Characterization of multipotent cells from human adult hair follicles. Toxicol In Vitro (2006) 0.84
Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme-altered islands in rat liver by carcinogens. Carcinogenesis (1989) 0.84
Sexual dimorphism in the regulation of cell turnover during liver hyperplasia. Chem Biol Interact (1995) 0.83
Cell proliferation in rat kidney induced by 1,2-dibromoethane. Toxicol Lett (1987) 0.83
Cholesterol and phospholipid composition of mitochondria and microsomes isolated from morris hepatoma 5123 and rat liver. FEBS Lett (1973) 0.83
Ploidy and nuclearity of rat hepatocytes after compensatory regeneration or mitogen-induced liver growth. Carcinogenesis (1993) 0.83
Labelling of liver and plasma lecithins after injection of 1-2-14C-2-demethylaminoethanol and 14C-L-methionine-methyl to choline deficient rats. Lipids (1969) 0.83
Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-cis retinoic acid, and 3,3',5-triiodo-L-thyronine. Cancer Res (1997) 0.82
Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol (1997) 0.82
Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. Lab Invest (1994) 0.82
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. Dev Dyn (1998) 0.82
Characterization and induction of human pre-adipocytes. Toxicol In Vitro (2006) 0.81
The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis (1995) 0.81
Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha. Hepatology (1996) 0.81
Protein kinase C isozyme pattern in liver hyperplasia. Biochem Biophys Res Commun (1994) 0.81
The resistance phenotype in the development and treatment of cancer. Lancet Oncol (2000) 0.81
Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model. Jpn J Cancer Res (1993) 0.81
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector. Phys Rev Lett (2013) 0.81
Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice. Mol Pharmacol (2009) 0.81
Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis (1999) 0.81
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency. Eur J Epidemiol (1992) 0.81
Chronic mitoinhibition during promotion of hepatocarcinogenesis. Dig Dis Sci (1991) 0.80
Enhancement of cholesterol synthesis and pentose phosphate pathway activity in proliferating hepatocyte nodules. Carcinogenesis (1985) 0.80
Early exposure to restraint stress enhances chemical carcinogenesis in rat liver. Cancer Lett (2000) 0.80
Lymphocyte subpopulations in blood and cerebrospinal fluid from patients with subacute sclerosing panencephalitis. Acta Neurol Scand (1983) 0.80
The changes in some hydrolytic enzymes in carbon tetrachloride-induced fatty livers. Biochem J (1964) 0.80
Mechanisms of the enhanced liver carcinogenesis by choline in female rats: delay in liver growth after partial hepatectomy and stimulation of 2-AAF mitoinhibition. Carcinogenesis (1992) 0.80
Genetic mapping and expression analysis of the murine DNA ligase I gene. Mol Carcinog (1995) 0.80
Hexose monophosphate shunt and cholesterogenesis in lead-induced kidney hyperplasia. Chem Biol Interact (1987) 0.80
Hexose monophosphate shunt and cholesterol synthesis in the diabetic and fasting states. Exp Mol Pathol (1985) 0.80
Effects of the CCl 4 -cycloheximide interaction on protein synthesis and lipid metabolism in rat liver. Biochem Pharmacol (1971) 0.80
Serum lipoproteins during bone marrow hyperplasia after phenylhydrazine administration in rats. Int J Exp Pathol (1990) 0.80
Genotoxic and non-genotoxic activities of 2,4- and 2,6-diaminotoluene, as evaluated in Fischer-344 rat liver. Toxicology (1995) 0.80
Failure of mitogen-induced cell proliferation to achieve initiation of rat liver carcinogenesis. Carcinogenesis (1987) 0.80
Basic fibroblast growth factor in human pheochromocytoma: a biochemical and immunohistochemical study. Int J Cancer (1993) 0.80
Differential effects of choline administration on liver microsomes of female and male rats. Exp Mol Pathol (1978) 0.80
Affinity purification and characterization of protein gene product 9.5 (PGP9.5) from retina. Biochem J (1996) 0.79
Hepatocyte proliferation induced by a single dose of a peroxisome proliferator. Am J Pathol (1996) 0.79
Lead nitrate induces certain biochemical properties characteristic of hepatocyte nodules. Carcinogenesis (1986) 0.79
Lead and liver cell proliferation. Effect of repeated administrations. Am J Pathol (1983) 0.79
Hexose monophosphate shunt enzymes in lung tumors from normal and glucose-6-phosphate-dehydrogenase-deficient subjects. Oncology (1988) 0.79
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. Int J Dev Neurosci (1995) 0.79